DBV Technologies | Betriebsaufwand



Operating Expenses Veränderung Datum
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amarin USD 58.77M 56.06M 2025-03
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
DBV Technologies USD 27.37M 3M 2025-03
Halozyme Therapeutics USD 123.28M 48K 2025-06
Incyte USD 904.7M 56.97M 2025-06
Insmed USD 361.29M 20.33M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Neurocrine Biosciences USD 541.9M 7M 2025-06
PTC Therapeutics USD 213.73M 7.86M 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
United Therapeutics USD 521.7M 110.1M 2025-06


DBV Technologies Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.